Helicobacter pylori infection and ulcer;Helicobacter-pylori-infektion und ulcuskrankheit

Chirurg

Volumn 69, Issue 3, 1998, Pages 239-248

  Malfertheiner, P ^a   Blum, A L ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

Helicobacter pylori; Pathogenesis; Treatment; Ulcer

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE;

DRUG COMBINATION; DRUG EFFECT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; PATHOGENICITY; PEPTIC ULCER; REVIEW; TREATMENT OUTCOME; VIRULENCE;

AMOXICILLIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PEPTIC ULCER; TREATMENT OUTCOME; VIRULENCE;

EID: 0032017851     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050405     Document Type: Article

References (76)

1. Atherton JC, Cao P, Peek RM, et al (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270: 1771
2. Bayerdörffer E, Mannes GA, Sommer A, et al (1992) High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol 4: 697
3. Bayerdörffer E, Miehlke St, Mannes GA, et al (1995) Double-Blind Trial of Omeprazole and Amoxicillin to Cure Helicobacter pylori Infection in Patients With Duodenal Ulcers. Gastroenterology 108: 1412
4. Bazzoli F, Zagari RM, Fossi S, et al (1994) Short term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol 6: 773
5. Blair AJ, Feldmann M, Barnett C, et al (1987) Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations on duodenal ulcer subjects. J Clin Invest 79: 582
6. Borody TJ, Brandi S, Andrews P, et al (1994) Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 89: 33
7. Burget DW, Chiverton SG, Hunt RH (1990) Is there an optimal degree of acid suppression for healing duodenal ulcers? Gastroenterology 99: 345
8. Censini S, Lange C, Xiang Z, et al (1996) cagA pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93: 14648
9. Chan FKL, Sung JJY, Chung SC, et al (1997) Randomised trial of eradication of Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers. Lancet 350: 975
10. Coghlan JG, Gilligan D, Humphries H, et al (1987) Campylobacter pylori and recurrence of duodenal ulcers: a 12-month follow-up study. Lancet II: 1109
11. Cook DJ, Guyatt GH, Salena BJ, Laine LA (1992) Endoscopic therapy for acute gastrointestinal hermorrhage: a meta-analysis. Gastroenterology 102: 139
12. Cox AJ (1952) Stomach size and it's relation to chronic peptic ulcer. Arch Pathol 54: 407
13. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al (1994) Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 47: 61
14. Daneshmend TK, Hawkey CJ, Langman MJS, et al (1992) Omeprazole versus placebo for acute upper gastrointestinal bleeding: a randomised double-blind controlled trial. Br Med J 304: 143
15. de Boer WA, Driessen WM, Potters VP, Tytgat GN (1994) Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 89: 1993
16. El-Omar E, Penman I, Ardill JE, et al (1995) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109: 681
17. El-Omar E, Penman I, Ardill JES, et al (1993) The exaggerated acid response to GRP ind DU patients completely resolves following eradication of Helicobacter pylori, Gut [Suppl 4] 34: S 49
18. European H. pylori study group (corresp. author: Malfertheiner P) (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1: 8
19. Eysselein VE, Kkovacs TOG, Kleibeuker JH, et al (1992) Regulation of gastric acid secretionn by gastrin in duodenal ulcer patients and healthy subjects. Gastroenterology 102: 1142
20. Graham DY, Hepps KS, Ramirez FC, et al (1993) Treatment of H. pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 28: 939
21. Graham DY, Lew GM, Malaty HM, et al (1992) Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102: 493
22. Green FW, Kaplan MM, Curtis LE, Levine PH (1978) Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal haemorrhage. Gastroenterology 74: 38
23. Haruma, K, Kawaguchi H, Yoshibara H, et a! (1994) Relationship between Helicobacter pylori infection and gastric acid secretion in young healthy subjects. J Clin Gastroenterol 19: 20
24. Jaspersen D, Koerner T, Schorr W, et al (1995) Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage: Gastrointest Endosc 41: 5
25. Khulusi S, Badve S, Patel P, et al (1996) Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid and ulceration. Gastroenterology 110: 452
26. Kreiss Ch, Blum A, Malfertheiner P (1995) Peptic ulcer pathogenesis. The Year in H. pylori. Current science, p 25
27. Labenz J, Blum AL, Bayerdörffer E, et al (1997) Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112: 1442
28. Labenz J, Börsch G (1994) Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 55: 19
29. Labenz J, Leverkus F, Boersch G (1994) Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors governing the treatment success. Scand J Gastroenterol 29: 1070
30. Labenz J, Malfertheiner P (1997) Helicobacter pylori in gastrooesophageal reflux disease: causal agent, independent or protective factor? Gut 41: 277
31. Labenz J, Tillenburg B, Peitz U, et al (1996) Ulkusheilung durch Helicobacter pylori Eradikation: genügt eine Woche Therapie?, Dtsch Med Wochenschr 121: 3
32. Lam SK (1984) Pathogenesis and pathophysiology of duodenal ulcer. Clin Gastroenterol 13: 447
33. Logan RPH, Walker MM, Misiewicz JJ, et al (1995) Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36: 12
34. Macri G, Milani S, Surrenti E, et al (1996) Eradication of Helicobacter pylori decreases the rate of duodenal ulcer recurrence and rebleeding. Gut 39: A143
35. Maier M, Schilling D, Doriars D, et al (1995) Eradication of H. pylori or H2 blocker maintenance therapy after peptic ulcer bleeding - a prospective randomized trial. Gastroenterology 108: 156
36. Malfertheiner P (1993) Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol [Suppl 196] 28: 34
37. Malfertheiner P (Hrsg) (1996) Helicobacter pylori in der Ulkuspathogene. H.-pylori - Von der Grundlage zur Therapie. Thieme, Stuttgart, S 89
38. Malfertheiner P, Bode G (1993) Helicobacter pylori and the pathogenesis of duodenal ulcer disease. Eur J Gastroenterol [Suppl 1] 5: 51
39. Malfertheiner P, Halter F (1994) Peptic ulcer pathogenesis. The Year in H. pylori. Current science, p 30
40. Malfertheiner P, Bayerdörffer E, Labenz J, Rösch W (1997) Therapie bei peptischen Ulzera. Dt Ärztebl 94 (Heft 13): A833
41. Malfertheiner P, Hackelsberger A, Dominguez E, et al (1997) Is the H. pylori negativ bleeding duodenal ulcer (DU) a myth? Gastroenterology 112: A208
42. Marshall B, Warren JR (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis (letter). Lancet I: 1273
43. Marshall BJ, Goodwin CS, Warren JR, et al (1988) Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet II: 1437
44. McColl KEL, El-Omar E (1994) Effect of H. pylori infection on gastrin and gastric acid secretion. In: Hunt RH, Tytgat GNJ (eds) Helicobacter pylori. Basic Mechanisms to Clinical Cure. Kluwer, Dordrecht, p 245
45. Mc Henry L Jr., Vuyuru L, Schubert ML (1993) Helicobacter pylori and duodenal ulcer disease: the somatostatin link? Gastroenterology 104: 1573
46. Moss SF, Calam J (1993) Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 34: 888
47. Moss SF, Legon S, Bishop AE, et al (1992) Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340: 930
48. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease (1994) Helicobacter pylori in peptic ulcer disease. JAMA 272: 65
49. Nilius M, Malfertheiner P (1996) Helicobacter-pylori-Infektion - Pathogenese, Entzündung und immunologische Reaktionen. In: Malfertheiner P (Hrsg) H.-pylori - Von der Grundlage zur Therapie. Thieme, Stuttgart, S 25
50. Noah LA, RoLf TM, Bosma NB, et al (1993) Gastric metaplasia and Helicobacter pylori infection. Gut 34: 1510
51. Olbe L, Hamlet A, Dalenbäck J, et al (1996) A Mechanism by Which Helicobacter pylori infection of the Antrum contributes to the Development of Duodenal Ulcer. Gastroenterology 110: 1386
52. Panoz MZ, Walt RP (1993) Current management of bleeding peptic ulcer: a review. Drugs 46: 269
53. Parente F, Maconi G, Sangaletti O, et al (1995) Behaviour of acid secretion, gastrin release, serum pepsinogen I and gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients. A controlled study. Gut 37: 210
54. Peitz U, Malfertheiner P (1998) Therapie der Helicobacter pylori Infektion. Z Verdauungskrankh (im Druck)
55. Queiroz DMM, Mendes EN, Rocha GA, et al (1993) Effect of Helicobacter pylori eradication on antral gastrin and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 28: 858
56. Rauws EAJ, Tytgat GNJ (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet II: 1233
57. Rokkas T, Karameris A, Mavrogeorgis A, et al (1995) Eradication of H. pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 41: 1
58. Salandin S, Dal Bo N, Grassi SA, et al (1996) Eradication of H. pylori infection in preventing duodenal ulcer bleeding: one year interim report in a prospective five year study. Gut 39: A28
59. Santander C, Grávalos RG, Gómez-Cedenilla A, et al (1996) Antimicrobial therapy for H. pylori infection versus long-term maintenance antisecretion therapy in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 91: 1549
60. Savarino V, Mela GS, Zentilin P, et al (1997) 24-Hour Gastric pH and Extent of Duodenal Gastric Metaplasia in Helicobacter pylori-Positive Patients. Gastroenterology 113: 741
61. Sipponen P, Seppala K, Aarynen M, et al (1989) Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 30: 922
62. Soil AH (1996) Medical Treatment of Peptic Ulcer Disease - Practice Guidelines. JAMA 275: 622
63. Stolte M (1996) Pathologie der Helicobacter-pylori-Krankheiten. In: Malfertheiner P (Hrsg) H.-pylori - Von der Grundlage zur Therapie. Thieme, Stuttgart, S 37
64. Stolte M, Bethke B (1990) Elimination of H. pylori under treatment with omeprazole. Z Gastroenterol 28: 271
65. Tomb J-F, White O, Kerlavage AR, et al (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539
66. Tytgat GNJ (1997) H. pylori and peptic ulcer disease - how to diagnose, how to treat. In: Podolsky DK, Friedmann LS (eds) Gastroenterology in the centennial year and beyond. American Gastroenterological Association, Bethesda, p 23
67. Tytgat GNJ, Axon ATR, Dixon ME, et al (1990) Helicobacter pylori: causal agent in peptic ulcer disease? Working party report of the World Congresses of Gastroenterology 1990. Blackwell, Melbourne, p 36
68. Tytgat GNJ, Lee A, Graham DY, et al (1993) The Role of Infectious Agents in Peptic Ulcer Disease. Gastroenterol Int 6: 76
69. van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ (1996) Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1: 6
70. Wagner S, Haruma K, Gladziwa U, et al (1994) Helicobacter infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 89: 1211
71. Warren JR, Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis (letter). Lancet I: 1273
72. Wilcox CM (1997) Relationship Between Nonsteroidal Antiinflammatory Drug Use, H. pylori, and Gastroduodenal Mucosal Injury. Gastroenterology 113: 85
73. Bercik P, Verdú EF, Armstrong D, et al (1996) H. pylori related increase in omeprazole (OME) effect is associated with ammonia production. Gastroenterology 110: A64
74. Verdú EF, Armstrong D, Idström JP, et al (1995) Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 37: 743
75. Verdú EF, Armstrong D, Idström JP, et al (1996) Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. Scand J Gastroenterol 31: 1151
76. Labenz J, Tillenburg B, Peitz U, et al (1996) Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110: 725